نتائج البحث - "I. Juez-Martel"

1

Differences in the disclosure of a cancer diagnosis by healthcare professionals and the repercussions on patients’ emotions and health

المؤلفون: E. Ruiz Sancho, M.A. Pérez Nieto, F. Román, L. León, F. Sánchez Escamilla, S. Enrech Francés, M.A. Pérez Escutia, I. Juez Martel, P. Pérez-Segura, A. Aguirre, M. Redondo Delgado

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::ff1fbb13db61c61f459a990f9e99d66f
https://doi.org/10.21203/rs.3.rs-2495051/v1

2

Second line in pancreatic cancer: Resuming our experience and looking for prognostic factors

المؤلفون: B. Anton, J. Guerra Martinez, M. de Torres Olombrada, B. Losada Vila, I. Juez Martel, J. Letéllez, A. Fernñandez Román, F. Longo Muñoz, D. Gutierrez Abad

المساهمون: Servicio de Oncología. Hospital Universitario de Fuenlabrada, Servicio de Farmacia. Hospital Universitario de Fuenlabrada, Servicio de Oncología Radioterápica. Hospital Universitario de Fuenlabrada

المصدر: Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
Consejería de Sanidad de la Comunidad de Madrid

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Pronóstico, Hematology, Prognosis, medicine.disease, Pancreatic Neoplasms, Second line, Internal medicine, Pancreatic cancer, Medicine, business, Neoplasias Pancreáticas

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98c2baab35122252a8ec48a6bbd7ff1c
https://doi.org/10.1093/annonc/mdy151.161

3

In the pathway to response: Is aflibercept an optimal treatment for RASwt mCRC patients after progression to 1st line containing anti-EGFR?

المؤلفون: M.J. Safont Aguilera, J.M. Cabrera Romero, M. Salgado Fernandez, F. Rivera Herrero, A. Ruiz Casado, C. Pericay Pijaume, E. Mata Velasco, P. Iranzo Gomez, B. Gonzalez Astorga, I. Juez Martel, V. Alonso, C. López, Pilar Escudero, R. Vera, N. Martinez Lago, E. González-Flores

المصدر: Annals of Oncology. 29:viii160-viii161

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, business.industry, Optimal treatment, Hematology, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, 030220 oncology & carcinogenesis, Internal medicine, Medicine, Line (text file), business, Aflibercept, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::914fa2dff8f209544a28d0084213807b
https://doi.org/10.1093/annonc/mdy281.026

4

P-051Preliminary clinical and pathologic characteristics of patients treated in second-line (2L) with 25 cycles (Cy) or more of FOLFIRI + Aflibercept (FA)

المؤلفون: E. Mata Velasco, J.C. Méndez Méndez, I. Macías Declara, N. Martínez-Lago, I. Juez Martel, Nohra Cecilia Rodríguez, J.A. Barrera Ramírez, D. Cacho Lanvin, Monica Corral, O. Donnay, V. Calderero Aragón, Beatriz García-Paredes, M.T. Delgado Urena, Carles Pericay, Beatriz González-Astorga, A. Ruiz Casado, Teresa Macarulla

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Hematology, 03 medical and health sciences, Abstracts, 0302 clinical medicine, Text mining, Second line, 030220 oncology & carcinogenesis, Internal medicine, medicine, FOLFIRI, 030211 gastroenterology & hepatology, business, Aflibercept, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a8780e8e97b4a4dd91f8912063669aa
https://europepmc.org/articles/PMC4984099/

5

Pancreatic ductal adenocarcinoma (PDAC) and type 2 diabetes mellitus: Cause or consequence? Analysis of the prevalence of alterations in glucose metabolism (AGM) in a patients’ cohort with PDAC

المؤلفون: C. Sánchez Cendra, I. Juez Martel, M. de Torres Olombrada, M. Pantin Gonzalez, L. Medina Rodriguez, D. Gutierrez Abad

المصدر: Annals of Oncology. 29:v40

مصطلحات موضوعية: medicine.medical_specialty, Pancreatic ductal adenocarcinoma, Oncology, business.industry, Internal medicine, Cohort, medicine, Type 2 Diabetes Mellitus, Hematology, Carbohydrate metabolism, Consequence analysis, business, Gastroenterology

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::9eae86d39e51622f2b3c0d148d460580
https://doi.org/10.1093/annonc/mdy151.143

6

P-145 Metastases resection following FOLFIRI-aflibercept in refractory patients to first-line chemotherapy: safety and efficacy analysis

المؤلفون: I. Juez Martel, Oliver Higuera, S. García Adrián, A. Moreno Santos Ma, Nohra Cecilia Rodríguez, P. Ibeas Millan, R. Grandez Ladrón de Guevara, Carles Pericay, P. García Alfonso, A. Ruiz Casado, I. Machengs Bruquetas, I. González Cebrián, M. Lobo de Mena, S. Encinas García, Ismael Ghanem, J. Alcaide García, M. Lopez Muñoz Ana, E. Díaz Peña, Alejandra Muñoz

المصدر: Annals of Oncology. 27:ii42

مصطلحات موضوعية: medicine.medical_specialty, business.industry, Hematology, Chemotherapy regimen, Resection, Surgery, Abstracts, Text mining, Oncology, Refractory, medicine, FOLFIRI, First line chemotherapy, business, Aflibercept, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::547ca39f709841e852b5d952344d187d
https://doi.org/10.1093/annonc/mdw199.139

7

P-042 Institutional experience in induction chemotherapy and neoadjuvant IMRT for borderline resectable and locally advanced pancreatic adenocarcinoma

المؤلفون: T. García Cañibano, I. Juez Martel, F. Pereira Perez, M. de Torres Olombrada, D. Gutierrez Abad, B. Ludeña Martinez

المصدر: Annals of Oncology. 26:iv11

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, medicine.medical_treatment, Locally advanced, Induction chemotherapy, Hematology, Intensity-modulated radiation therapy, medicine.disease, Borderline resectable, Internal medicine, medicine, Adenocarcinoma, business, Neoadjuvant therapy

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::4886b9227270c2e2bd90050a095d35f0
https://doi.org/10.1093/annonc/mdv233.42

8

P-041 Patterns of failure in pancreatic cancer: results review

المؤلفون: I. Juez Martel, F. Pereira Perez, M. de Torres Olombrada, D. Gutierrez Abad, C. Rodríguez Rodríguez, T. García Cañibano

المصدر: Annals of Oncology. 26:iv11

مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Pancreatic cancer, Internal medicine, Medicine, Cancer, CA19-9, Hematology, business, medicine.disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::6e1049b04c0b6616762635d06b5cbc1e
https://doi.org/10.1093/annonc/mdv233.41

9

Rare site of recurrence in metastatic pancreatic cancer: Regarding a case report

المؤلفون: I. Juez Martel, J. Calzas Rodriguez, J. Guerra Martinez, B. Losada Vila, D. Gutierrez Abad, M. de Torres Olombrada, D. Malón Giménez, L. Rodríguez Lajusticia

المصدر: Pancreatology. 15:e9

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::684b9e9f24a786d9d017037534df0625
https://doi.org/10.1016/j.pan.2015.05.023

View record from ScienceDirect

Full Text via ClinicalKey

10

Multidisciplinary Treatment Outcome of Desmoid-Type Fibromatosis (Dtf). a Registry-Based Study from Spanish Group for Research on Sarcoma (Geis)

المصدر: Annals of Oncology. 25:iv507

مصطلحات موضوعية: medicine.medical_specialty, Chemotherapy, business.industry, medicine.medical_treatment, Hematology, medicine.disease, Gastroenterology, Chemotherapy regimen, Surgery, Radiation therapy, Stable Disease, Oncology, Internal medicine, medicine, Sarcoma, Progression-free survival, Radical surgery, business, Progressive disease

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c5f7d6d6104f30906163338d092c93b8
https://doi.org/10.1093/annonc/mdu354.41

تنقيح النتائج